Shares of Astronics Corporation (NASDAQ:ATRO) received a significant boost from analysts this week, with Wall Street Zen upgrading the stock from a buy rating...
Adaptive Biotechnologies Corporation (NASDAQ: ADPT) has received a consensus rating of “Moderate Buy” from ten analysts, according to MarketBeat.com. This rating reflects a mix...